Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 High seroprevalence of neutralizing capacity against human metapneumovirus in all age groups studied in Bonn, Germany.

Literature DB >> 20042516

High seroprevalence of neutralizing capacity against human metapneumovirus in all age groups studied in Bonn, Germany.

Jessica Lüsebrink¹, Christoph Wiese, Anne Thiel, Ramona-Liza Tillmann, Vanessa Ditt, Andreas Müller, Oliver Schildgen, Verena Schildgen.

Abstract

Human metapneumovirus (hMPV) infections occur frequently despite high rates of perpetual seroprevalence for all age groups. Analyses of approximately 2,000 archived, randomly selected serum samples demonstrated that neutralizing capacities remain high, with a minor decrease for individuals over 69 years of age, leading to the hypothesis that reinfections occur because humoral immune responses play minor roles in the clearance of hMPV infections.

Entities: Species

Mesh：

Substances：

Year: 2009 PMID： 20042516 PMCID： PMC2837972 DOI： 10.1128/CVI.00398-09

Source DB: PubMed Journal: Clin Vaccine Immunol ISSN： 1556-679X

22 in total

1. Human metapneumovirus associated with respiratory tract infections in a 3-year study of nasal swabs from infants in Italy.

Authors: Fabrizio Maggi; Massimo Pifferi; Marialinda Vatteroni; Claudia Fornai; Elena Tempestini; Silvia Anzilotti; Letizia Lanini; Elisabetta Andreoli; Vincenzo Ragazzo; Mauro Pistello; Steven Specter; Mauro Bendinelli
Journal: J Clin Microbiol Date: 2003-07 Impact factor: 5.948

Review 2. Clinical impact and diagnosis of human metapneumovirus infection.

Authors: Bernadette G van den Hoogen; D M E Osterhaus; Ron A M Fouchier
Journal: Pediatr Infect Dis J Date: 2004-01 Impact factor: 2.129

3. Human metapneumovirus infection in the United States: clinical manifestations associated with a newly emerging respiratory infection in children.

Authors: Frank Esper; Derek Boucher; Carla Weibel; Richard A Martinello; Jeffrey S Kahn
Journal: Pediatrics Date: 2003-06 Impact factor: 7.124

4. High seroprevalence of human metapneumovirus among young children in Israel.

Authors: Dana G Wolf; Zichria Zakay-Rones; Ayman Fadeela; David Greenberg; Ron Dagan
Journal: J Infect Dis Date: 2003-12-05 Impact factor: 5.226

5. Human metapneumovirus infection in the Canadian population.

Authors: Nathalie Bastien; Diane Ward; Paul Van Caeseele; Ken Brandt; Spencer H S Lee; Gail McNabb; Brian Klisko; Edward Chan; Yan Li
Journal: J Clin Microbiol Date: 2003-10 Impact factor: 5.948

6. Human HepG2 cells support respiratory syncytial virus and human metapneumovirus replication.

Authors: Verena Schildgen; Jessica Lüsebrink; Vanessa Ditt; Ramona Tillmann; Arne Simon; Andreas Müller; Oliver Schildgen
Journal: J Virol Methods Date: 2009-09-30 Impact factor: 2.014

7. Comparison of the seroprevalence of human metapneumovirus and human respiratory syncytial virus.

Authors: Takashi Ebihara; Rika Endo; Hideaki Kikuta; Nobuhisa Ishiguro; Hiroaki Ishiko; Kunihiko Kobayashi
Journal: J Med Virol Date: 2004-02 Impact factor: 2.327

8. Characterization of human metapneumoviruses isolated from patients in North America.

Authors: Teresa C T Peret; Guy Boivin; Yan Li; Michel Couillard; Charles Humphrey; Albert D M E Osterhaus; Dean D Erdman; Larry J Anderson
Journal: J Infect Dis Date: 2002-05-03 Impact factor: 5.226

9. A newly discovered human pneumovirus isolated from young children with respiratory tract disease.

Authors: B G van den Hoogen; J C de Jong; J Groen; T Kuiken; R de Groot; R A Fouchier; A D Osterhaus
Journal: Nat Med Date: 2001-06 Impact factor: 53.440

10. Antigenic and genetic variability of human metapneumoviruses.

Authors: Bernadette G van den Hoogen; Sander Herfst; Leo Sprong; Patricia A Cane; Eduardo Forleo-Neto; Rik L de Swart; Albert D M E Osterhaus; Ron A M Fouchier
Journal: Emerg Infect Dis Date: 2004-04 Impact factor: 6.883

14 in total

Review 1. Modulation of Host Immunity by the Human Metapneumovirus.

Authors: Pablo F Céspedes; Christian E Palavecino; Alexis M Kalergis; Susan M Bueno
Journal: Clin Microbiol Rev Date: 2016-10 Impact factor: 26.132

2. Lung CD8+ T Cell Impairment Occurs during Human Metapneumovirus Infection despite Virus-Like Particle Induction of Functional CD8+ T Cells.

Authors: Sherry C Wen; Jennifer E Schuster; Pavlo Gilchuk; Kelli L Boyd; Sebastian Joyce; John V Williams
Journal: J Virol Date: 2015-06-10 Impact factor: 5.103

Review 3. Human Metapneumovirus: lessons learned over the first decade.

Authors: Verena Schildgen; Bernadette van den Hoogen; Ron Fouchier; Ralph A Tripp; Rene Alvarez; Catherine Manoha; John Williams; Oliver Schildgen
Journal: Clin Microbiol Rev Date: 2011-10 Impact factor: 26.132

4. Seroepidemiologies of human metapneumovirus and respiratory syncytial virus in young children, determined with a new recombinant fusion protein enzyme-linked immunosorbent assay.

Authors: Sarah R Dunn; Alex B Ryder; Sharon J Tollefson; Meng Xu; Benjamin R Saville; John V Williams
Journal: Clin Vaccine Immunol Date: 2013-08-14

Review 5. Human metapneumovirus in adults.

Authors: Lenneke E M Haas; Steven F T Thijsen; Leontine van Elden; Karen A Heemstra
Journal: Viruses Date: 2013-01-08 Impact factor: 5.048

6. Seroprevalence of human respiratory syncytial virus and human metapneumovirus in healthy population analyzed by recombinant fusion protein-based enzyme linked immunosorbent assay.

Authors: Patricia Sastre; Tamara Ruiz; Oliver Schildgen; Verena Schildgen; Carmen Vela; Paloma Rueda
Journal: Virol J Date: 2012-07-02 Impact factor: 4.099

7. Human metapneumovirus in the preterm neonate: current perspectives.

Authors: Nathalie L Maitre; John V Williams
Journal: Res Rep Neonatol Date: 2016-07-28

8. RSV and HMPV seroprevalence in Tuscany (Italy) and North-Rhine Westfalia (Germany) in the winter season 2009/2010.

Authors: Maria G Cusi; Chiara Terrosi; Michael Kleines; Oliver Schildgen
Journal: Influenza Other Respir Viruses Date: 2011-04-18 Impact factor: 4.380

9. Immunologic Profiling of Human Metapneumovirus for the Development of Targeted Immunotherapy.

Authors: Ifigeneia Tzannou; Sarah K Nicholas; Premal Lulla; Paibel I Aguayo-Hiraldo; Anisha Misra; Caridad A Martinez; Annette A Machado; Jordan S Orange; Pedro A Piedra; Juan F Vera; Ann M Leen
Journal: J Infect Dis Date: 2017-09-15 Impact factor: 5.226

Review 10. Human metapneumovirus - what we know now.

Authors: Nazly Shafagati; John Williams
Journal: F1000Res Date: 2018-02-01